HOME >> MEDICINE >> NEWS
Studies suggest investigational agent reduces disease activity in MS

BOSTON A new drug under investigation shows a reduction in disease activity in multiple sclerosis (MS), according to two studies that will be presented at the American Academy of Neurology's 59th Annual Meeting in Boston, April 28 May 5, 2007. The drug reduced disease activity as indicated by MRI scans.

Both of the studies involved people with the relapsing-remitting form of MS, where symptoms flare up and then subside. By 24 weeks, treatment with the drug rituximab reduced the number of areas of brain damage, or lesions, in people with MS and the number of relapses, or times when symptoms flare up, when compared with placebo.

Rituximab is a therapeutic antibody that selectively targets and depletes a subset of immune cells called B-cells by targeting a specific protein on their surface.

"This is the first drug to target B-cells and may represent a potential new treatment strategy for relapsing-remitting MS," said study author Stephen Hauser, MD, of the University of California, San Francisco, and a member of the American Academy of Neurology. "While these are early stage clinical trials, these results are exciting, because the current drugs available for MS are only partially effective in reducing disease activity and preventing exacerbations. New and more effective treatments for MS are sorely needed, especially for people who do not adequately respond to currently available medications. These data are also important because they demonstrate that B-cells, which are the precursors of antibody-producing cells, play an essential role in mediating relapses of MS."

In the first study, a randomized, placebo-controlled trial, 69 people were given two infusions of rituximab two weeks apart and 35 were given a placebo. The participants were followed for six months. Those given rituximab had approximately 90 percent fewer brain lesions than those given placebo. During the six-month period, 58 percent fewer of those taking the d
'"/>

Contact: Angela Babb
ababb@aan.com
651-695-2789
American Academy of Neurology
1-May-2007


Page: 1 2 3

Related medicine news :

1. Studies show antidepressants not linked to birth defects
2. Studies show role of age, gender, race and weight on cancer risk and treatment
3. Studies highlight advances in diagnosis, medical therapy
4. Studies highlight real world use, safety of drug-eluting stents
5. Studies led by Rhode Island Hospital confirm safety and efficacy
6. Studies identify food sources of disease and drug resistance
7. Studies provide new evidence on risks associated with Cox-2 inhibitors and NSAIDs
8. Studies highlight need to monitor heart function in breast cancer patients
9. Studies examine physician disclosure of medical errors
10. Studies indicate medication can be an effective therapy for smoking cessation
11. Studies evaluating health effects of dental amalgam fillings in children confirm safety

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/19/2019)... ... February 19, 2019 , ... The American ... (CMAC). Originally developed and launched by the Center for Case Management in 2000, ... management administrators, managers, supervisors and leaders. , “I created the CMAC credential ...
(Date:2/19/2019)... Mass. (PRWEB) , ... February 19, 2019 , ... ... the impact of weight stigma in pregnant and postpartum women, a team led ... during pregnancy and early postpartum often show increased depressive symptoms, greater weight gain ...
(Date:2/19/2019)... ... February 19, 2019 , ... ... delivery technologies and development solutions for drugs, biologics and consumer health products, ... at the annual US Bioassay Conference of the BioPharmaceutical Emerging Best Practices ...
(Date:2/19/2019)... ... February 19, 2019 , ... Tap water ... based in The Villages FL proudly serving over 3,500 satisfied customers. I’m looking ... the greater Jacksonville area selling and installing our popular Water Filtration Systems," says ...
(Date:2/19/2019)... , ... February 19, 2019 , ... ... Clover Creek Cultivation LLC , a newly-licensed cannabis cultivation and manufacturing company ... and ethanol extraction, distillation, and ISO-7 product formulation, while Clover Creek is poised ...
Breaking Medicine News(10 mins):
(Date:2/22/2019)... ... February 22, 2019 , ... On Thursday, Feb. 14, Dutch Bros Coffee and its customers celebrated ... million meals for local food banks in seven states. , “To provide quality food for ... Bros. “Being a part of this special day is an honor.” , Dutch Bros donated ...
(Date:2/19/2019)... S.C. (PRWEB) , ... February 20, 2019 , ... ... Missing College Courses: Important Information That Is Nearly Never Covered in a University or ... each of his book’s 36 chapters is not covered in undergraduate courses of a ...
(Date:2/19/2019)... ... February 19, 2019 , ... ... Job Syndrome by providing the scientific community with additional opportunities to further research ... as Chief Scientific Officer of the Foundation’s Scientific Advisory Board and the addition ...
Breaking Medicine Technology:
Cached News: